1. Home
  2. ETON vs ALTI Comparison

ETON vs ALTI Comparison

Compare ETON & ALTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eton Pharmaceuticals Inc.

ETON

Eton Pharmaceuticals Inc.

HOLD

Current Price

$16.84

Market Cap

498.8M

Sector

Health Care

ML Signal

HOLD

Logo AlTi Global Inc.

ALTI

AlTi Global Inc.

HOLD

Current Price

$5.18

Market Cap

394.0M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ETON
ALTI
Founded
2017
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
498.8M
394.0M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
ETON
ALTI
Price
$16.84
$5.18
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$29.67
N/A
AVG Volume (30 Days)
270.8K
156.1K
Earning Date
11-06-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$70,316,000.00
$226,717,000.00
Revenue This Year
$113.27
$19.78
Revenue Next Year
$36.70
$7.00
P/E Ratio
N/A
N/A
Revenue Growth
102.77
N/A
52 Week Low
$11.09
$2.33
52 Week High
$23.00
$5.45

Technical Indicators

Market Signals
Indicator
ETON
ALTI
Relative Strength Index (RSI) 49.52 78.03
Support Level $16.13 $4.29
Resistance Level $17.05 $5.45
Average True Range (ATR) 0.76 0.33
MACD 0.16 0.13
Stochastic Oscillator 79.06 85.92

Price Performance

Historical Comparison
ETON
ALTI

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

About ALTI AlTi Global Inc.

AlTi Global Inc is an independent wealth and asset manager providing entrepreneurs, multi-generational families, institutions, and emerging next-generation leaders with fiduciary capabilities as well as alternative investment strategies and advisory services. The firm has business which is organized into two business segments namely: Wealth & Capital Solutions and the International Real Estate segment includes providing holistic solutions for wealth management clients through comprehensive range of wealth management services, including investment management and advisory services. International Real Estate segment includes assist investors with real estate co-investments, structuring and selecting partners with a track record with risk adjusted return characteristics.

Share on Social Networks: